AQUESTIVE THERAPEUTICS INC (AQST) Stock Analyst Earnings Estimates
NASDAQ:AQST - Nasdaq - US03843E1047 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.83M 10.86% | 47.68M -6.20% | 50.583M 6.09% | 59.911M 18.44% | 54.01M -9.85% | 73.3M 35.72% | 140.22M 91.30% | 191.1M 36.29% | 282.44M 47.80% | 404.91M 43.36% | 645.66M 59.46% | 833.54M 29.10% | |
| EBITDA YoY % growth | -31.72M 19.59% | -39.68M -25.09% | -13.757M 65.33% | -19.907M -44.71% | -23.743M -19.27% | -11.118M 53.17% | 25.245M 327.06% | 70.278M 178.38% | 128.83M 83.31% | 196.86M 52.81% | 217.16M 10.31% | N/A | |
| EBIT YoY % growth | -34.68M 19.14% | -42.07M -21.31% | -15.102M 64.10% | -27.43M -81.63% | -43.66M -59.17% | -47.285M -8.30% | 39.066M 182.62% | 8.721M -77.68% | 54.774M 528.07% | 111.18M 102.98% | 157.39M 41.56% | 281.62M 78.93% | |
| Operating Margin | -68.23% | -88.23% | -29.86% | -45.79% | -80.84% | -64.51% | 27.86% | 4.56% | 19.39% | 27.46% | 24.38% | 33.79% | |
| EPS YoY % growth | -1.49 9.70% | -1.14 23.49% | -0.36 68.42% | -0.47 -30.33% | -0.62 -32.61% | -0.54 13.66% | -0.09 82.91% | 0.28 400.00% | 0.79 185.19% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -25.84% | -0.14 20.00% | -0.14 -376.00% | -0.15 -12.46% | -0.15 -10.53% | 0.04 126.25% | 0.02 112.86% | 0.02 112.56% | 0.02 110.00% |
| Revenue Q2Q % growth | 13.345M 21.34% | 13.158M 9.17% | 13.158M -34.53% | 13.702M 1.18% | 15.062M 12.87% | 24.427M 85.64% | 24.493M 86.15% | 24.546M 79.14% | 25.861M 71.70% |
| EBITDA Q2Q % growth | -7.943M -209.56% | -8.6M 1.71% | -8.358M -1,889.70% | -7.963M -3.16% | -11.029M -38.84% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.763M -149.62% | -10.455M -16.72% | -11.373M -20,778.18% | -12.189M -47.03% | -13.464M -37.91% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.13 -333.33% | -0.13 | 0.00 | -0.62% |
| Q2 2024 Q2Q % growth | -0.03 70.00% | -0.13 | 0.10 | 76.28% |
| Q1 2024 Q2Q % growth | -0.17 -41.67% | -0.08 | -0.09 | -102.44% |
| Q4 2023 Q2Q % growth | -0.11 52.17% | -0.08 | -0.03 | -34.80% |
| Q3 2023 Q2Q % growth | -0.03 86.96% | -0.12 | 0.09 | 74.02% |
| Q2 2023 Q2Q % growth | -0.10 72.22% | -0.12 | 0.02 | 16.92% |
| Q1 2023 Q2Q % growth | -0.12 62.50% | -0.19 | 0.07 | 37.75% |
| Q4 2022 Q2Q % growth | -0.23 39.47% | -0.24 | 0.01 | 2.30% |
| Q3 2022 Q2Q % growth | -0.23 37.84% | -0.32 | 0.09 | 27.73% |
| Q2 2022 Q2Q % growth | -0.36 -9.09% | -0.37 | 0.01 | 1.96% |
| Q1 2022 Q2Q % growth | -0.32 21.95% | -0.42 | 0.10 | 23.11% |
| Q4 2021 Q2Q % growth | -0.38 36.67% | -0.48 | 0.10 | 20.31% |
| Q3 2021 Q2Q % growth | -0.37 24.49% | -0.46 | 0.09 | 19.39% |
| Q2 2021 Q2Q % growth | -0.33 -371.43% | -0.45 | 0.12 | 26.13% |
| Q1 2021 Q2Q % growth | -0.41 16.33% | -0.43 | 0.02 | 5.64% |
| Q4 2020 Q2Q % growth | -0.60 -25.00% | -0.27 | -0.33 | -126.24% |
| Q3 2020 Q2Q % growth | -0.49 9.26% | -0.47 | -0.02 | -5.35% |
| Q2 2020 Q2Q % growth | -0.07 91.46% | -0.44 | 0.37 | 84.11% |
| Q1 2020 Q2Q % growth | -0.49 16.95% | -0.48 | -0.01 | -3.09% |
| Q4 2019 Q2Q % growth | -0.48 | -0.40 | -0.08 | -20.66% |
| Q3 2019 Q2Q % growth | -0.54 | -0.71 | 0.17 | 23.64% |
| Q2 2019 Q2Q % growth | -0.82 | -0.64 | -0.18 | -28.97% |
| Q1 2019 Q2Q % growth | -0.59 | -0.52 | -0.07 | -14.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 13.542M 18.70% | 12.937M | 605K | 4.68% |
| Q2 2024 Q2Q % growth | 20.099M 51.79% | 12.628M | 7.471M | 59.16% |
| Q1 2024 Q2Q % growth | 12.053M 8.25% | 12.508M | -455K | -3.64% |
| Q4 2023 Q2Q % growth | 10.998M 2.98% | 11.864M | -866K | -7.30% |
| Q3 2023 Q2Q % growth | 11.409M -0.45% | 11.744M | -335K | -2.85% |
| Q2 2023 Q2Q % growth | 13.241M -0.22% | 11.232M | 2.009M | 17.89% |
| Q1 2023 Q2Q % growth | 11.134M -9.26% | 10.136M | 998K | 9.85% |
| Q4 2022 Q2Q % growth | 10.68M -3.61% | 10.625M | 55K | 0.52% |
| Q3 2022 Q2Q % growth | 11.46M -13.77% | 11.258M | 202K | 1.79% |
| Q2 2022 Q2Q % growth | 13.27M -13.55% | 10.784M | 2.486M | 23.05% |
| Q1 2022 Q2Q % growth | 12.27M 10.34% | 10.313M | 1.957M | 18.98% |
| Q4 2021 Q2Q % growth | 11.08M 54.97% | 9.549M | 1.531M | 16.03% |
| Q3 2021 Q2Q % growth | 13.29M 60.90% | 11.234M | 2.056M | 18.30% |
| Q2 2021 Q2Q % growth | 15.35M -29.20% | 9.665M | 5.685M | 58.82% |
| Q1 2021 Q2Q % growth | 11.12M 26.80% | 9.147M | 1.973M | 21.57% |
| Q4 2020 Q2Q % growth | 7.15M -56.46% | 6.377M | 773K | 12.12% |
| Q3 2020 Q2Q % growth | 8.26M -33.49% | 8.897M | -637K | -7.16% |
| Q2 2020 Q2Q % growth | 21.68M 94.79% | 8.941M | 12.739M | 142.48% |
| Q1 2020 Q2Q % growth | 8.77M -30.62% | 10.274M | -1.504M | -14.64% |
| Q4 2019 Q2Q % growth | 16.42M | 16.158M | 262K | 1.62% |
| Q3 2019 Q2Q % growth | 12.42M | 10.172M | 2.248M | 22.10% |
| Q2 2019 Q2Q % growth | 11.13M | 9.367M | 1.763M | 18.82% |
| Q1 2019 Q2Q % growth | 12.64M | 11.822M | 818K | 6.92% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.7% | 0.7% | 0.36% | 0.72% |
| Revenue | -0.08% | -0.08% | 0% | -0.01% |